Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Hahn

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Psychology|April 25, 2020
Widening Access to Bayesian Problem SolvingNicole Cruz, Saoirse Connor Desai, Stephen Dewitt, et al.
The Annals of the American Academy of Political and Social Science|November 7, 2022
When Science Becomes Embroiled in Conflict: Recognizing the Public's Need for Debate while Combating Conspiracies and MisinformationStephan Lewandowsky, Konstantinos Armaos, Hendrik Bruns, et al.
International Journal of Cancer|November 4, 2014
The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoproteinUlrich Deuschle, Manfred Birkel, Eva Hambruch, et al.
Frontiers in Immunology|December 19, 2013
In the crosshairs: investigating lytic granules by high-resolution microscopy and electrophysiologyVarsha Pattu, Mahantappa Halimani, Min Ming, et al.
European Journal of Pharmacology|May 11, 2011
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritisAndrea Mencarelli, Eleonora Distrutti, Barbara Renga, et al.
Vaccine|February 9, 2007
Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccineRoland Grunow, Mustafa Porsch-Ozcürümez, Wolf Splettstoesser, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2016
Novel substituted isoxazole FXR agonists with cyclopropyl, hydroxycyclobutyl and hydroxyazetidinyl linkers: Understanding and improving key determinants of pharmacological propertiesOlaf Kinzel, Christoph Steeneck, Thomas Schlüter, et al.
ACS Pharmacology & Translational Science|December 19, 2024
A Defined Diet Combined with Sonicated Inoculum Provides a High Incidence, Moderate Severity Form of Experimental Autoimmune Encephalomyelitis (EAE)Mariella Martorelli, Matthias Dengler, Julian Laux, et al.
Nature Communications|February 25, 2022
Identification of distinct cytotoxic granules as the origin of supramolecular attack particles in T lymphocytesHsin-Fang Chang, Claudia Schirra, Momchil Ninov, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 25, 2012
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) miceEva Hambruch, Shinobu Miyazaki-Anzai, Ulrike Hahn, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Psychology|April 25, 2020
Widening Access to Bayesian Problem SolvingNicole Cruz, Saoirse Connor Desai, Stephen Dewitt, et al.
The Annals of the American Academy of Political and Social Science|November 7, 2022
When Science Becomes Embroiled in Conflict: Recognizing the Public's Need for Debate while Combating Conspiracies and MisinformationStephan Lewandowsky, Konstantinos Armaos, Hendrik Bruns, et al.
International Journal of Cancer|November 4, 2014
The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoproteinUlrich Deuschle, Manfred Birkel, Eva Hambruch, et al.
Frontiers in Immunology|December 19, 2013
In the crosshairs: investigating lytic granules by high-resolution microscopy and electrophysiologyVarsha Pattu, Mahantappa Halimani, Min Ming, et al.
European Journal of Pharmacology|May 11, 2011
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritisAndrea Mencarelli, Eleonora Distrutti, Barbara Renga, et al.
Vaccine|February 9, 2007
Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccineRoland Grunow, Mustafa Porsch-Ozcürümez, Wolf Splettstoesser, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2016
Novel substituted isoxazole FXR agonists with cyclopropyl, hydroxycyclobutyl and hydroxyazetidinyl linkers: Understanding and improving key determinants of pharmacological propertiesOlaf Kinzel, Christoph Steeneck, Thomas Schlüter, et al.
ACS Pharmacology & Translational Science|December 19, 2024
A Defined Diet Combined with Sonicated Inoculum Provides a High Incidence, Moderate Severity Form of Experimental Autoimmune Encephalomyelitis (EAE)Mariella Martorelli, Matthias Dengler, Julian Laux, et al.
Nature Communications|February 25, 2022
Identification of distinct cytotoxic granules as the origin of supramolecular attack particles in T lymphocytesHsin-Fang Chang, Claudia Schirra, Momchil Ninov, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 25, 2012
Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) miceEva Hambruch, Shinobu Miyazaki-Anzai, Ulrike Hahn, et al.
Pageof 9